La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Imagion Biosystems Résultats passés
Passé contrôle des critères 0/6
Imagion Biosystems's earnings have been declining at an average annual rate of -20.9%, while the Medical Equipment industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 14.9% per year.
Informations clés
-20.9%
Taux de croissance des bénéfices
24.2%
Taux de croissance du BPA
| Medical Equipment Croissance de l'industrie | 5.8% |
| Taux de croissance des recettes | 14.9% |
| Rendement des fonds propres | n/a |
| Marge nette | -250.9% |
| Dernière mise à jour des bénéfices | 31 Dec 2023 |
Mises à jour récentes des performances passées
Recent updates
Here's Why We're Watching Imagion Biosystems' (ASX:IBX) Cash Burn Situation
Dec 13
Here's Why We're Watching Imagion Biosystems' (ASX:IBX) Cash Burn Situation
Aug 30We're Not Very Worried About Imagion Biosystems' (ASX:IBX) Cash Burn Rate
Feb 22We're Hopeful That Imagion Biosystems (ASX:IBX) Will Use Its Cash Wisely
Sep 09We're Not Very Worried About Imagion Biosystems' (ASX:IBX) Cash Burn Rate
May 03Imagion Biosystems (ASX:IBX) Has Rewarded Shareholders With An Exceptional 582% Total Return On Their Investment
Feb 28Here's Why We're Not Too Worried About Imagion Biosystems' (ASX:IBX) Cash Burn Situation
Jan 06Ventilation des recettes et des dépenses
Comment Imagion Biosystems gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 31 Dec 23 | 5 | -12 | 10 | 0 |
| 30 Sep 23 | 4 | -12 | 10 | 0 |
| 30 Jun 23 | 3 | -12 | 9 | 0 |
| 31 Mar 23 | 3 | -11 | 9 | 0 |
| 31 Dec 22 | 3 | -10 | 8 | 0 |
| 30 Sep 22 | 2 | -10 | 7 | 0 |
| 30 Jun 22 | 0 | -10 | 6 | 0 |
| 31 Mar 22 | 2 | -8 | 6 | 0 |
| 31 Dec 21 | 3 | -6 | 6 | 0 |
| 30 Sep 21 | 3 | -6 | 6 | 0 |
| 30 Jun 21 | 3 | -5 | 6 | 0 |
| 31 Mar 21 | 3 | -5 | 5 | 0 |
| 31 Dec 20 | 3 | -5 | 5 | 0 |
| 30 Sep 20 | 3 | -5 | 4 | 0 |
| 30 Jun 20 | 2 | -4 | 4 | 0 |
| 31 Mar 20 | 2 | -4 | 4 | 0 |
| 31 Dec 19 | 2 | -3 | 3 | 0 |
| 30 Sep 19 | 2 | -4 | 4 | 0 |
| 30 Jun 19 | 2 | -5 | 5 | 0 |
| 31 Mar 19 | 1 | -7 | 5 | 0 |
| 31 Dec 18 | 0 | -8 | 6 | 0 |
| 30 Sep 18 | 0 | -8 | 6 | 1 |
| 30 Jun 18 | 0 | -8 | 6 | 1 |
| 31 Mar 18 | 0 | -8 | 5 | 2 |
| 31 Dec 17 | 0 | -8 | 5 | 2 |
| 31 Dec 16 | 0 | -12 | 1 | 6 |
| 31 Dec 15 | 0 | -4 | 0 | 4 |
| 31 Dec 14 | 0 | -3 | 0 | 2 |
Des revenus de qualité: IBX is currently unprofitable.
Augmentation de la marge bénéficiaire: IBX is currently unprofitable.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: IBX is unprofitable, and losses have increased over the past 5 years at a rate of 20.9% per year.
Accélération de la croissance: Unable to compare IBX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Bénéfices par rapport au secteur d'activité: IBX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).
Rendement des fonds propres
ROE élevé: IBX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.